AI assistant
Sending…
Qualigen Therapeutics, Inc. — Director's Dealing 2015
Jun 25, 2015
35251_dirs_2015-06-24_f3e4e73e-5a1a-4190-8050-b0bcc6c20653.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2015-06-24
Reporting Person: MAIER PAUL V (Director)
More from Qualigen Therapeutics, Inc.
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 14
Annual Report
2026
Mar 30
Regulatory Filings
2026
Feb 27
Board/Management Information
2026
Feb 17
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 29
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 6
Audit Report / Information
2025
Dec 16
Proxy Solicitation & Information Statement
2025
Dec 15